No Data
The Tokyo Stock Exchange Growth Index continues to decline, with lackluster price movements ahead of the Japan and US central bank meetings.
Tokyo Stock Exchange Growth Market Index 814.89 -2.43 / Volume 0.2 billion 14.75 million shares / Trading value 145.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 635.44 -2.83 / Volume 0.1 billion 5.09 million shares / Trading value 97.2 billion yen Today's growth market saw a continued decline in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, with 187 rising stocks, 363 declining stocks, and 45 unchanged. Today's growth market showed a soft trend. On the previous day, October 16 in the USA.
Afternoon session [Active stocks and traded stocks]
*DM Solyu <6549> 1302 +4425 fiscal year Dividends Financial Estimates revised upward. *Muromachi Chemical <4885> 828 +36 First half profit estimates revised upward. *Tokyo Base <3415> 306 -21 Operating profit for the cumulative third quarter increased by 75.6%, but the progress rate against the full-year forecast remains at 40.2%. *Qualips <4894> 5330 +705 Joint research contract with Stanford Universities Department of Cardiothoracic Surgery. *Asiro <7378> 1711 +
Emerging Markets Stock Digest: DWTI and Daiwa Cycle hit the daily limit.
Fanpeep (4881) is in a slight decline of 130. It was announced that a joint collaboration agreement has been signed with i-Brain Science regarding the Alzheimer’s Disease Vaccine. i-Brain Science has already obtained regulatory approval for the neuropsychological testing program 'Milevo,' which uses a generic tablet as a diagnostic aid for dementia, on October 5, 2023. The company is conducting drug discovery research for an Alzheimer’s Disease Vaccine targeting 'phosphorylated tau' from November 2023.
Daiwa Cycle --- Trading at the upper limit, upward revision of the full-year Financial Estimates for the January 2025 period.
The stock reached its daily limit high and updated its year-to-date high. After the close of Trade on the 16th, a revision of the full-year performance Financial Estimates for the period ending January 2025 was announced, which was well received. For the Financial Estimates for the period ending January 2025, revenue was revised upward from 17.745 billion yen to 18.312 billion yen (a 3.2% increase), and operating profit was revised upward from 1.091 billion yen to 1.34 billion yen (a 22.8% increase). Based on the results up to the third quarter, the full-year performance Financial Estimates were examined, resulting in revenue projected to exceed the previously announced Financial Estimates, which also affected the operating profit.
Stocks reaching the upper and lower limits in the first half of the trading session.
■ Limit up <218A> Liberaware <4935> Liberta <5134> POPER <5888> DAIWA CYCLE <7378> Ashiro <8783> GFA <9562> Business Coach ■ Limit down <3775> Gaia Inc ※ Includes temporary limit up and down (displayed prices).
December 17th [Today's Investment Strategy]
[Fisco Selected Stocks] [Material Stocks] Zojirushi Mahobin <7965> 1568 yen (12/16) engages in cooking appliances, home appliances, and living products. The financial estimates for the fiscal year ending November 2024 have been revised upward. The operating profit is expected to be 5.955 billion yen (an increase of 19.1% compared to the previous period). This is about a 14% increase from the previous estimates. The pressure IH rice cookers and humidifiers, centered around the top model 'Enbu Daki', are performing well. The efforts to pass on the increased costs to prices have also contributed to this success. [Emerging]
No Data